跳至主要内容
MedPath Trial logoMedPath TrialMedPath Trial Home
临床试验/CTRI/2009/091/000586
CTRI/2009/091/000586已完成4 期

An open, prospective, single centre study to assess the confidence, usability, preference and satisfaction on use of peak flow master in healthy volunteers and in subjects with mild Asthma or COPD.

Cipla Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

试验速览

阶段
4 期
状态
已完成
发起方
Cipla Ltd
入组人数
30
研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • •1.Subjects and healthy volunteers willing to sign informed consent
  • •2.Subjects and healthy volunteers of 18 years and above
  • •3.Subjects with or without a respiratory condition. Each subject with a respiratory condition (prior experience of using an device) should be matched as far as possible with an individual without a respiratory condition (device naïve) with respect to the age, sex, literacy status etc
  • •4.Subjects with mild Asthma or COPD or healthy volunteer.
  • •5.Subjects who are only English speaking

排除标准

  • •1.Subjects already using Peak flow master prior to start of the study.
  • •2.Subjects with co-ordination problems like Parkinson?s disease, mental illness, tremors etc.

研究者

发起方
Cipla Ltd

相似试验

已完成
4 期
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat spacer in healthy volunteersand in subjects with mild Asthma or COPD.
CTRI/2014/03/004448Cipla Ltd30
已完成
4 期
A clinical trial to assess the confidence, usability, preference and satisfaction on use of Baby Mask with valve from parents of children who are healthy or who have mild Asthma.
CTRI/2009/091/000958Cipla Ltd30
已完成
4 期
Study to assess the confidence, usability, preference and satisfaction on use of Zerostat-VT Spacer in healthy volunteers and in subjects with mild asthama or COPD
CTRI/2014/02/004432Cipla Ltd30
已完成
4 期
Study to assess the confidence, usability,preference and satisfaction on use of Zerostat-V spacer in healthy volunteersand in subjects with mild Asthma or COPD.
CTRI/2014/03/004462Cipla Ltd30
进行中（未招募）
1 期
Open, prospective, single-center study evaluating the efficacy and safety of 0.05% ingénol mebutate (Picato® 500) in the treatment of basal cell carcinomaStudy PICABAS
EUCTR2017-004608-22-FRCHU de Nice28
A clinical trial to assess the confidence,... | 临床试验